HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anne Barton Selected Research
Anne Barton Research Topics
Disease
100
Rheumatoid Arthritis
11/2022 - 05/2002
23
Arthritis (Polyarthritis)
01/2022 - 01/2004
17
Necrosis
10/2019 - 10/2007
16
Psoriasis (Pustulosis Palmaris et Plantaris)
06/2021 - 01/2004
10
Psoriatic Arthritis
06/2021 - 01/2004
8
Inflammation (Inflammations)
11/2022 - 07/2012
7
Autoimmune Diseases (Autoimmune Disease)
01/2018 - 03/2004
5
Joint Diseases (Joint Disease)
01/2016 - 06/2007
4
Rheumatic Diseases (Rheumatism)
01/2020 - 05/2015
4
Genetic Predisposition to Disease (Genetic Predisposition)
01/2019 - 03/2011
3
Crohn Disease (Crohn's Disease)
02/2014 - 03/2005
3
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2009 - 06/2005
2
Synovitis
10/2020 - 03/2019
1
Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021
1
Systemic Scleroderma (Systemic Sclerosis)
01/2021
1
Fatigue
10/2020
1
Infections
01/2019
1
Obesity
01/2018
1
Pneumonia (Pneumonitis)
12/2017
1
Spondylarthropathies
10/2017
1
Ankylosing Spondylitis
10/2017
1
Vasculitis (Vasculitides)
01/2017
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1
Disease Susceptibility (Diathesis)
04/2015
1
Genetic Risk Score
01/2015
1
Neoplasms (Cancer)
02/2014
1
Breast Neoplasms (Breast Cancer)
07/2013
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2011
Drug/Important Bio-Agent (IBA)
17
Pharmaceutical Preparations
IBA
11/2020 - 08/2013
16
Methotrexate (Mexate)
FDA Link
Generic
10/2021 - 02/2014
15
Biological Products
IBA
10/2020 - 01/2013
13
Tumor Necrosis Factor Inhibitors
IBA
10/2021 - 01/2011
13
Antibodies
IBA
01/2020 - 05/2010
13
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019 - 10/2007
10
HLA-DRB1 Chains (HLA DRB1)
IBA
01/2022 - 12/2004
9
Biomarkers (Surrogate Marker)
IBA
10/2021 - 12/2015
9
Autoantibodies
IBA
01/2021 - 06/2005
8
Anti-Citrullinated Protein Antibodies
IBA
01/2022 - 02/2008
7
Adalimumab (Humira)
FDA Link
11/2022 - 06/2014
7
Etanercept (Enbrel)
FDA Link
01/2019 - 03/2013
7
Proteins (Proteins, Gene)
FDA Link
01/2017 - 03/2004
7
Rheumatoid Factor
IBA
01/2016 - 01/2004
5
C-Reactive Protein
IBA
10/2020 - 10/2012
5
Antirheumatic Agents (DMARD)
IBA
10/2020 - 11/2008
5
Epitopes
IBA
01/2018 - 06/2007
5
ametantrone (HAQ)
IBA
11/2016 - 01/2010
5
cyclic citrullinated peptide
IBA
01/2016 - 02/2008
4
Amino Acids
FDA Link
01/2022 - 01/2015
4
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 01/2011
4
HLA-C Antigens (HLA-C)
IBA
08/2019 - 11/2010
4
Peptides (Polypeptides)
IBA
12/2012 - 05/2012
3
Genetic Markers (Genetic Marker)
IBA
11/2016 - 12/2012
3
Interleukin-13
IBA
08/2012 - 09/2010
2
RNA (Ribonucleic Acid)
IBA
01/2018 - 12/2015
2
HLA-B Antigens (HLA-B)
IBA
10/2017 - 01/2015
2
Valine (L-Valine)
FDA Link
11/2016 - 04/2015
2
Immunoglobulin G (IgG)
IBA
01/2016 - 03/2015
2
Infliximab (Remicade)
FDA Link
03/2015 - 06/2014
2
Antigens
IBA
01/2015 - 06/2007
2
Vitamin D
FDA Link
Generic
07/2014 - 05/2014
2
TNF Receptor-Associated Factor 1
IBA
02/2013 - 01/2010
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
12/2010 - 07/2010
2
Type II Tumor Necrosis Factor Receptors
IBA
05/2010 - 08/2005
2
Cytokines
IBA
10/2007 - 03/2005
1
Pharmacological Biomarkers
IBA
01/2020
1
Interleukin-10 (Interleukin 10)
IBA
10/2019
1
Interleukin-17 (Interleukin 17)
IBA
10/2019
1
amsonic acid (DAS)
IBA
03/2019
1
Chromatin
IBA
01/2019
1
Opioid Analgesics (Opioids)
IBA
01/2019
1
Steroids
IBA
01/2019
1
tocilizumab (atlizumab)
FDA Link
01/2019
1
Transcription Factors (Transcription Factor)
IBA
01/2018
1
HLA-A31 antigen
IBA
12/2017
1
Interleukin-4 (Interleukin 4)
IBA
11/2017
1
Serine (L-Serine)
FDA Link
10/2017
1
Asparagine
IBA
10/2017
1
Certolizumab Pegol
FDA Link
01/2017
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
11/2016
1
interleukin 20 (IL-20)
IBA
11/2016
1
Monoclonal Antibodies
IBA
11/2016
1
Interleukin-6 (Interleukin 6)
IBA
11/2016
1
CXC Chemokines
IBA
11/2015
1
Ligands
IBA
11/2015
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
07/2015
1
Anti-Idiotypic Antibodies
IBA
02/2015
1
HLA-DPB1 antigen (HLA DPB1)
IBA
01/2015
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
04/2014
1
IGF-I-IGFBP-3 complex
FDA Link
10/2012
1
HLA-B27 Antigen (HLA B27 Antigen)
IBA
08/2012
1
Rituximab (Mabthera)
FDA Link
07/2012
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2012
1
Phosphotransferases (Kinase)
IBA
01/2011
1
NF-kappa B (NF-kB)
IBA
07/2010
1
Enzymes
IBA
05/2010
1
Protein-Arginine Deiminase Type 4
IBA
04/2010
Therapy/Procedure
28
Therapeutics
11/2022 - 04/2009
6
Biological Therapy
10/2020 - 03/2013
3
Precision Medicine
01/2020 - 07/2015
1
Immunomodulation
01/2018